课题基金 / 基金详情

SIGNIFICANCE OF THE 68-K SERINE PROTEASE IN SERUM AS A MARKER PROTEIN FOR BRAIN AGING

SIGNIFICANCE OF THE 68-K SERINE PROTEASE IN SERUM AS A MARKER PROTEIN FOR BRAIN AGING
血清中 68-K 丝氨酸蛋白酶作为脑老化标记蛋白的意义
批准号:
09835008
负责人:
MATSUMOTO Akira
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

MATSUMOTO Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Genetation of beta-amyloid (Abeta) from native precursor protein (APP) and its accumulation which appear as senile plaque and amyloid angiopathy in human brain are essentially associated with normal aging and pathophysiology of Alzheimer's disease. Processing of APP and formation of Abeta-bearing peptides were comparatively analyzed between normal lymphoblastoid cells and those derived from familial AD patients. 68 kDa serine protease was purified from culture medium of AD cells, which cleaves oligopeptides at the Abeta-N-terminus. Though this protease cleaves native LAPP in the vicinity of Abeta-N- terminus, native brain APP was not degraded, suggesting a strict tissue specificity in APP proteolysis. I searched for activities capable of cleaving native brain APP in human hippocampus, and HBP49 proteolytic activity was isolated and characterized, and the molecular cloning clarified as being a novel protease. Biochemical and molecular biological analyses suggested a physiological function of the protease in brain APP degradation and generation of Abeta peptides, and a possible role of sulfated glycocon-jugates attached to brain APP in the proteolysis. Immunohistochemical study showed its expression in neuronal perikarya, and some unique lesions with the immunoreactivity were found in brains of sporadic AD patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Matumoto A.: "The β-amyloid epitope masking activity in human brain is identified as albumin." Neuroreport. 8. 3297-3301 (1997)
Matumoto A.:“人脑中的 β-淀粉样蛋白表位掩蔽活性被确定为白蛋白。” Neuroreport。8. 3297-3301 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A.Matsumoto et al.: "A novel human brain protease capable of generating natural beta-amyloid-containing peptides from natural substrate." Clin.Neurosci.51. 26-27 (1998)
A.Matsumoto 等人:“一种新型人脑蛋白酶,能够从天然底物产生天然的含 β-淀粉样蛋白的肽。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsumoto A,: "The β-amyloid epitope masking activity in human brain is identified as albumin." Neuroreport. 8. 3297-3301 (1997)
Matsumoto A,:“人脑中的 β-淀粉样蛋白表位掩蔽活性被确定为白蛋白。” Neuroreport。8. 3297-3301 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A Matsumoto et al.: "A human brain proteolytic activity capable of cleaving natural β-amyloid precursor protein is affected by its substrate glycoconjugates." Neurosci.Lett.242. 109-113 (1998)
A Matsumoto 等人:“能够裂解天然 β-淀粉样蛋白前体蛋白的人脑蛋白水解活性受到其底物糖缀合物的影响。” Neurosci.Lett.242 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    Smart-gel based synthetic artificial pancreas
    • 批准号:
      25560220
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MATSUMOTO Akira
    • 依托单位:
    Posttranscriptional regulation of clock genes by ABC protein
    • 批准号:
      24570199
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.58万
    • 财政年份:
      2012
    • 负责人:
      MATSUMOTO Akira
    • 依托单位:
    Development of Integrated Transistor Based device for Monitoring of Enzymatic Activities as Next-generation Platform for Apoptosis Pathways Analysis
    • 批准号:
      23680051
    • 项目类别:
      Grant-in-Aid for Young Scientists (A)
    • 资助金额:
      $18.05万
    • 财政年份:
      2011
    • 负责人:
      MATSUMOTO Akira
    • 依托单位:
    Civil Society, Nationstate and War in Modern Germany
    • 批准号:
      21520738
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      MATSUMOTO Akira
    • 依托单位:
    国内基金
    海外基金
    Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
    • 批准号:
      30971012
    • 项目类别:
      面上项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2009
    • 负责人:
      刘瑞田
    • 依托单位:
    抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
    • 批准号:
      30570622
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2005
    • 负责人:
      刘瑞田
    • 依托单位: